Oxime Derivatives of Erythromycin: Inhibitors of Rous Sarcoma Virus Reverse Transcriptase Activity and Focus Formation
(Accepted 19 September I974) SUMMARY 9-O-methyloxime erythromycin A and its analogue inhibited reverse transcriptase and blocked focus formation of Rous sarcoma virus. These chemicals inhibited neither DNA-dependent DNA polymerase nor DNA-dependent RNA polymerase from bacterial sources. However, they inhibited reverse transcriptase with an apparently different mechanism than that by rifamycin ABDP.
The discovery of an RNA-dependent DNA polymerase, reverse transcriptase (Baltimore, 197o; Temin & Mizutani, 197o) , in RNA turnout viruses of a variety of animal species (Duesberg & Canaani, 197o; Garapin et al. 197o; Hatanaka, Huebner & Gilden, I97o; Rokutanda et al. 197o; Scolniek, Aaronson & Todaro, 197o; Spiegelman et al. 197o) has raised the important question of the role of this enzyme in virus replication and cell transformation. Specific inhibitors of reverse transcriptase could be useful in analysing the role of this enzyme. Moreover, if reverse transcriptase is indeed essential in virus replication as believed, inhibitors for reverse transcriptase may provide a group of drugs useful in the prevention of virus infections. I now report that 9-O-methyloxime erythromycin A and its analogue, 9-O-ethyloxime erythromycin A, are inhibitors of reverse transcriptase in Rous sarcoma virus (RSV) with an apparently different inhibitory mechanism than that reported for rifamycin derivatives, and also block the formation of RSV induced foci in tissue culture. This class of compounds has not heretofore been associated with this type of activity.
The Bryan high titre strain of Rous sarcoma virus, RSV (RAV-I), was grown in chick embryo fibroblasts and was purified from large volumes of harvest medium as described previously (Wang et al. I973) . Reverse transcriptase activities in either virus or purified enzyme were measured from the incorporation of [aH]-thymidine triphosphate intoltrichloroacetic acid insoluble counts according to Spiegelman et al. (197o) . The enzyme was partially purified from about 400 E280 units of the purified virus with DEAE cellulose chromatography to yield about a 2o-fold enrichment of the enzyme as described previously (Hung I973) .
Inhibition of reverse transcriptase activity in virus particles by 9-O-methyloxime erythromycin was studied in reaction mixtures contained 12"5 ~mol of tris-HC1 (pH 8"3); 3 ~,mol MgC12; io #mol KC1; 2.5 #mol dithiothreitol; o'o4 #tool each of dATP, dGTP and dCTP; I/~C of [3H]-TTP (50 Ci/mmol); io #l of DMSO containing indicated amounts of the drug, and o.I E280 unit of RSV(RAV-I) which had been pre-incubated for IO min at o °C in the presence of o.z ~ Nonidet P-4o and o.i M-dithiothreitol. After 60 rain of incubation at 37 °C, samples from the reaction were pipetted on 3 MM filter paper discs to be washed 5 times in cold trichloroacetic acid (5 ~) containing sodium pyrophosphate (o.oi M). After drying, the discs were counted in a toluene scintillation solution with a Beckman scintillation spectrometer. Inhibition was linearly proportional to drug concentrations with no effect below IOO/~g/ml and a resistant fraction above 6oo/~g/ml. Fifty percent inhibition (IDs0) was observed at approx 35 ° ~g/ml. Similar results were obtained with the 9-O-ethyloxime I36 100 , 197o) . The drug in DMSO (lo mg/ml) was added to the medium at concentrations of I, 5, or lo t~g/ml. The cells were trypsinized each day and counted in a Coulter counter to determine the rate of growth. Each point represents measurements from duplicate plates. ©--©, I #g/ml; 0----0, 5/zg/ml; I1--11, Io/zg/ml; /A--Z~, zo/~g
analogue. Under identical conditions in my laboratory, rifamycins AF/oI3 and AF/DNFI (kindly supplied by Dr P. Sensi of Lepetit) gave IDs0 at approx. 400/zg/ml. Although these compounds inhibited reverse transcriptase from RSV, they inhibited neither DNA-dependent DNA polymerase nor DNA-dependent RNA polymerase from Escherichia colia drug concentration as high as 80o #g/ml. We are currently studying their specificity on DNA polymerases from animal cells.
Focus-forming units in tissue culture are greatly reduced in cells with decreased rate of growth (Robinson & Robinson, ~972; Ting, Yang & Gallo, I972 ) . Therefore meaningful interpretations of drug-induced inhibition of focus formation can be obtained only at drug concentrations not affecting cell division. Little or no effect on cell division of chick embryo fibroblasts was observed when concentrations of the erythromycin derivatives were io/~g/ml or lower (Fig. I) . The effects of the drugs on the blocking of transformation at these low concentrations are shown in 6, I2 95 I47, I38 (I #g/ml) lo9, IO4 25 (5 #g/ml) 59, 60 58 0o #g/ml) 2o, 23 85 * Drugs were dissolved in DMSO 0o mg/ml) and mixed with the virus at various concentrations before infection. The same concentration was also present in hard agar overlays in focus formation assays (HobomSchnegg, Robinson & Robinson, I97o).
t Chick embryo fibroblasts were infected with the Bryan high titre strain, RSV(RAV-I) in duplicates. Little is known about the mechanism of drugs in the inhibition of reverse transcriptase. We studied the effect of the drugs on the formation of reverse transcriptase-template complex with the millipore binding technique (Jones & Berg, 1966; Von der Helm & Krakow, 1972 ) . Reaction mixtures, in a total volume of IOO/d, contained the following: 2o/zl of reverse transcriptase purified'from DEAE cellulose chromatography (o.8 E2s0/ml; 5oo pmol TTP incorporation/E2so/6O min with dTrA as the template), I o #1 of [~H]-polydAT (5 #Ci/#molP, 4 #c/ml, Miles Labs.) and magnesium acetate (4raM), mercaptoethylamine (4raM), tris-HC1 8o mM, pH 8"3), and indicated amounts of drugs in DMSO (lO mg]ml) when used. The reaction mixture was incubated for I o rain at 37 °C, added with z ml of cold buffer ( I o mM-tris-HCl, pH 8. 3, 5o mM NaC1), chilled at o °C for 5 rain and filtered through a nitrocellulose membrane. After washing with 15 ml of the cold buffer, the membrane was dried and counted in a scintillation spectrometer. The results (Table 2) indicate that purified reverse transcriptase formed a complex with [ZH]-polydAT, and this enzyme-template complex was retained on a millipore membrane while unbound pH]-polydAT, either alone or with serum albumin, was not. Rifamycin ABDP inhibited effectively the complex between the template and reverse transcriptase. It is well known that rifamycins inhibit bacterial RNA polymerases by interfering with the formation of an initiation complex for DNA transcription (diMauro et al. I969; Sippel & Hartman, 197o; So & Downey, I97O) . In contrast to rifamycin ABDP, 9-O-ethyloxime erythromycin A had very little effect on the binding of reverse transcriptase to the template. Short communications
The erythromycin derivatives we reported here inhibited reverse transcriptase in vitro at considerably high concentrations (IDso = 35o/zg/ml). Direct comparisons indicated that it was as effective as rifamycins AF[oI3 and AF/DNFI. Although there is no direct proof that inhibition of the focus formation is related to the inhibition of reverse transcriptase, circumstantial evidence implicating reverse transcriptase in transformation has been reported (Hanafusa & Hanafusa, 197I; Ting et al. I972; Hung, 1973; Linial & Mason, 1973) . The concentrations required for inhibition of focus formation are a Ioo-fold less than those for inhibition of reverse transcriptase activity. Therefore, the drug could alternatively have a selective effect on the expression of cell transformation at these low doses without involving reverse transcriptase. However, preliminary experiments indicated that erythromycin derivatives greatly decreased the transforming activity of Rous sarcoma virus if cells were treated with the drug during the first two days after infection, suggesting that the drug interfered with the establishment of virus infection. There was little effect on focus formation after this period. Moreover, the drugs had an inhibitory effect on virus production. In the presence of the drug (IO/zg/ml) virus titres from dishes containing completely sheeted transformed cells decreased tenfold in four to five days, suggesting rather complicated modes of action by these drugs on not only transformation but also virus production. Further work will be required to elucidate in vivo mechanisms of drug action. Nevertheless, the enzyme inhibition as measured by the incorporation of thymidine triphosphate into acidinsoluble counts, is merely an indication of decreased activities of DNA synthesis and does not represent, in any way, the true biological significance of dlug efficacy. Even though a drug can inhibit only a small fraction of DNA synthesis, if it prevents the complete virus replication for its life cycle, the drug will be as good theoretically as others which cause a total inhibition. The blocking of Rous sarcoma virus infectivity in tissue culture by the compounds at much lower concentrations could be explained by the above supposition. For this reason, the important aspect is efficacy of the compounds in experiments in vivo. A crucial experiment which is in progress, is to test the efficacy of the drug in animals when they are challenged with sarcoma and leukaemia viruses.
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